Alefacept is indicated for:
Irrespective of gender only Adults (18 years old or older)
Alefacept is indicated is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 15 mg given once weekly
Treatment 2: Intravenous - 7.5 mg given once weekly
Active ingredient Alefacept is contraindicated in the following cases:
No gender/age discrimination
Alefacept should not be administered to patients infected with HIV. Alefacept reduces CD4+ T lymphocyte counts, which might accelerate disease progression or increase complications of disease in these patients.